After Male Breast Cancer: Why Every New or Persistent Symptom Deserves Attention
Written by: Lennard M. Goetze
Completing treatment for male breast cancer is an important milestone, but “cancer-free” does not mean that follow-up care should end. Most men treated for early-stage breast cancer will not experience a recurrence. Nevertheless, breast cancer can return months or years after treatment, and recognizing a concerning change may permit earlier diagnosis and more timely treatment. A previous cancer history should therefore increase clinical attentiveness—not become a reason to dismiss a new symptom as insignificant.
Men should report a new lump or thickening in the breast, chest wall, mastectomy scar or underarm. Other potentially important findings include persistent redness, ulceration, puckering, dimpling, warmth, skin thickening, nipple retraction or unexplained nipple discharge. Swelling above the collarbone, beneath the arm or along the chest may indicate an enlarged lymph node, although infection and other noncancerous conditions can produce similar findings. Arm or hand swelling may represent lymphedema resulting from lymph-node surgery or radiation, but new, rapidly worsening or unexplained swelling still requires evaluation.
Symptoms outside the chest also matter. Persistent, localized bone or back pain—particularly pain that worsens at night, occurs at rest or is not associated with an injury—may require assessment. Breast cancer can spread to bone, although arthritis, osteoporosis, muscle strain and treatment-related changes are far more common explanations. A fracture occurring after minimal trauma, new difficulty walking, leg weakness, numbness, or loss of bladder or bowel control demands urgent medical attention because spinal-cord compression must be excluded.
Possible lung-related symptoms include a persistent cough, increasing shortness of breath, wheezing, chest discomfort or coughing up blood. These symptoms may arise from asthma, infection, heart disease, a blood clot or treatment-related injury, as well as cancer. Sudden breathlessness, severe chest pain, fainting or coughing blood should be treated as an emergency rather than deferred to a routine oncology appointment.
Liver involvement may produce persistent right-upper abdominal discomfort, loss of appetite, nausea, abdominal swelling, itching, dark urine or yellowing of the skin and eyes. Possible neurological warning signs include a new or progressively worsening headache, seizures, confusion, personality changes, impaired balance, visual or speech changes, or weakness or numbness on one side. Sudden neurological symptoms warrant emergency evaluation because stroke and other immediately dangerous conditions must also be considered.
General symptoms—such as unintended weight loss, unusual fatigue, reduced appetite, recurring nausea or a decline in physical functioning—are less specific. They are commonly caused by medication effects, hormonal therapy, anemia, infection, sleep problems, depression or other medical conditions. Their importance lies in persistence, progression, lack of an obvious explanation or occurrence alongside more localized signs. Men should not assume that every ache indicates recurrence, but neither should they repeatedly ignore a change that is new, worsening or unresolved.
Evaluation begins with a careful history and physical examination. The clinician should review the original tumor’s stage, lymph-node involvement, estrogen-receptor, progesterone-receptor and HER2 status, previous treatments, current medications and hereditary risk. Testing is then directed by the symptom. It may include diagnostic mammography or ultrasound for a chest-wall or breast abnormality; CT, MRI, PET or bone imaging for suspected distant disease; and laboratory studies when liver, blood or metabolic abnormalities are possible. A suspicious lesion generally requires biopsy because imaging alone cannot definitively establish whether it represents recurrence, a new primary cancer or a benign condition.
Routine whole-body scans and tumor-marker blood tests are generally not recommended for asymptomatic survivors of early-stage breast cancer because they have not been shown to improve outcomes and can generate false alarms. Symptoms or abnormal examination findings, however, change the equation and may create a clear indication for diagnostic testing. The American Cancer Society specifically notes that men generally do not require routine blood or imaging tests after treatment unless signs or symptoms suggest possible recurrence. American Cancer Society
The practical message is vigilance without panic. Survivors should maintain scheduled follow-up visits, follow their individualized survivorship plan and promptly document when a symptom began, whether it is worsening and what makes it better or worse. If a concern is dismissed but persists, requesting reassessment or an oncology review is reasonable. Having “beaten” breast cancer should never disqualify a man’s new symptoms from thoughtful medical evaluation.
No comments:
Post a Comment